Here are four things to know:
1. SpineGuard reported 23 percent growth in its first-quarter 2017 revenue.
2. The company’s global revenue in the first quarter of 2017 grew 20 percent over the first quarter global revenue in 2016.
3. SpineGuard sold 2,397 units in the first quarter of 2017 compared to the 2,134 sold in the first quarter of 2016.
4. SpineGuard CEO and Co-Founder Pierre Jérôme said, “In line with former quarters, SpineGuard is starting 2017 with strong growth driven by great momentum in the US and the traction of PediGuard Threaded, the latest addition of our smart, single-use drilling probes.”
More articles on devices:
Baxter highlights FLOSEAL hemostatic agent enhancements for spine, cardiac surgery: 5 highlights
Implanet intends to transfer share listing from Euronext to Alternext Paris: 5 key notes
Spinal implant 3D printing: 5 findings from 2 key cases
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
